Fujian Cosunter Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2023: -2.56%

Fujian Cosunter Pharmaceutical Co Ltd (300436) has an Asset Resilience Ratio of -2.56% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥-43.49 Million

≈ $-6.36 Million USD Cash + Short-term Investments

Total Assets

CN¥1.70 Billion

≈ $248.30 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2016)

This chart shows how Fujian Cosunter Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check Fujian Cosunter Pharmaceutical Co Ltd (300436) strategic investment index to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Fujian Cosunter Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300436 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-43.49 Million	-2.56%
Total Liquid Assets	CN¥-43.49 Million	-2.56%

Asset Resilience Insights

Limited Liquidity: Fujian Cosunter Pharmaceutical Co Ltd maintains only -2.56% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Fujian Cosunter Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Fujian Cosunter Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Tonghua Dongbao Pharmaceutical Co Ltd SHG:600867	Drug Manufacturers - Specialty & Generic	0.76%
Beijing Winsunny Pharmaceutical CO.LTD SHG:601089	Drug Manufacturers - Specialty & Generic	10.89%
Akums Drugs and Pharmaceutical NSE:AKUMS	Drug Manufacturers - Specialty & Generic	28.08%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Tibet Weixinkang Medicine Co Ltd SHG:603676	Drug Manufacturers - Specialty & Generic	40.81%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%

Annual Asset Resilience Ratio for Fujian Cosunter Pharmaceutical Co Ltd (2015–2016)

The table below shows the annual Asset Resilience Ratio data for Fujian Cosunter Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2016-12-31	7.14%	CN¥50.00 Million ≈ $7.32 Million	CN¥700.67 Million ≈ $102.53 Million	-42.81pp
2015-12-31	49.94%	CN¥300.00 Million ≈ $43.90 Million	CN¥600.70 Million ≈ $87.90 Million	--

pp = percentage points

About Fujian Cosunter Pharmaceutical Co Ltd

SHE:300436 China Drug Manufacturers - Specialty & Generic

Market Cap

$2.13 Billion

CN¥14.55 Billion CNY

Market Cap Rank

#5910 Global

#1095 in China

Share Price

CN¥91.36

Change (1 day)

+0.96%

52-Week Range

CN¥73.20 - CN¥172.22

All Time High

CN¥172.22